Nutex Health substantially expanded operations from 26 hospital facilities while executing significant reverse stock splits totaling 1-for-150 in 2024.
The company appears to be in a major growth phase, substantially expanding its hospital network and revenue base while maintaining profitability. However, the aggressive reverse stock splits (1-for-150 combined ratio) typically signal previous share price distress and potential dilution concerns that investors should monitor closely.
The company demonstrated substantial growth across key metrics, with revenue growing meaningfully and current assets expanding significantly to $538.8M. Net income increased by over one-third to $70.8M, indicating the revenue expansion translated to improved profitability. The overall financial picture suggests successful operational scaling, though higher interest expense reflects increased financing costs to support this growth.
Current assets grew 84.2% — improving short-term liquidity or inventory/receivables build.
Strong top-line growth of 82.4% — accelerating demand or successful expansion into new markets.
R&D spending cut 48.7% — could signal cost discipline or concerning reduction in innovation investment.
Asset base grew 40.2% — expansion through organic growth, acquisitions, or capital deployment.
Net income grew 35.7% — bottom-line growth signals improving overall business health.
Interest expense surged 30.6% — significant debt increase or rising rates materially impacting earnings.
Current liabilities rose 12.1% — increased short-term obligations, watch current ratio.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →